Peginesatide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for peginesatide acetate and what is the scope of freedom to operate?
Peginesatide acetate
is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Peginesatide acetate has one hundred and fourteen patent family members in thirty-four countries.
Summary for peginesatide acetate
International Patents: | 114 |
US Patents: | 6 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | peginesatide acetate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for peginesatide acetate
US Patents and Regulatory Information for peginesatide acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-007 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-004 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-004 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-001 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-006 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for peginesatide acetate
International Patents for peginesatide acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Poland | 1625156 | ⤷ Sign Up | |
Austria | 428727 | ⤷ Sign Up | |
Singapore | 162747 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES | ⤷ Sign Up |
Mexico | PA05012316 | PEPTIDOS NOVEDOSOS QUE SE UNEN AL RECEPTOR DE LA ERITROPOYETINA. (NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR.) | ⤷ Sign Up |
Australia | 2006255081 | Erythropoietin receptor peptide formulations and uses | ⤷ Sign Up |
Montenegro | P53308 | NOVI PEPTIDI KOJI SE VEZUJU ZA RECEPTOR ERITROPOIETINA (NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |